Aflibercept biosimilar (Samsung Bioepis) | Interleukin Related interleukin-related.com

Product Name :
Aflibercept biosimilar (Samsung Bioepis)

Search keywords :
PLGF

drugId :
null

Target Vo:
Vascular endothelial growth factor A

Target Vo Short Name :
VEGFA

Moa_Name:
Vascular endothelial growth factor A inhibitors

First Approval Country :
United States

First Approval Date Filter:
2024

Origin Company_Name :
Samsung Bioepis Co Ltd

Active Company_Name :
Affamed Therapeutics Ltd

Active Indication_Name:
Macular Edema

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD9 Rabbit mAb medchemexpress
Phospho-PLK1(T210)Rabbit mAb custom synthesis
Anti-Mouse IgG H&L (FITC): Anti-Mouse IgG H&L (FITC) is a FITC-conjugated and Goat origined monoclonal antibody, targeting to Mouse IgG antibody. Anti-Mouse IgG H&L (FITC) can binds to the light and heavy chains of Mouse IgG antibodies, thus can be used for ICC/IF, FC assays in the background of Mouse.

Author: Interleukin Related

Related Posts